This inventor holds 1 USPTO granted patent. Top assignee: Nour Heart, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Elgebaly A Salwa: Innovator in Phosphagen Synthesis
Introduction
Elgebaly A Salwa is a notable inventor based in Edgewater, MD (US). He has made significant contributions to the field of biochemistry, particularly in the synthesis of phosphagen compounds. His innovative work has led to the development of a stable product that can be produced in large quantities from inexpensive starting materials.
Latest Patents
Elgebaly A Salwa holds a patent for the synthesis of Cyclocreatine phosphate. This patent highlights his ability to create a stable product that is essential for various biochemical applications. The patent is a testament to his expertise and dedication to advancing scientific knowledge in this area. He has 1 patent to his name.
Career Highlights
Salwa is currently associated with Nour Heart, Inc., where he continues to explore new avenues in his field. His work at the company focuses on innovative solutions that can improve health outcomes. His career reflects a commitment to research and development in biochemistry.
Collaborations
Elgebaly A Salwa collaborates with Ahmed Farghaly, who is also involved in similar research endeavors. Their partnership exemplifies the importance of teamwork in advancing scientific discoveries.
Conclusion
Elgebaly A Salwa is a distinguished inventor whose work in phosphagen synthesis has the potential to impact various industries. His contributions to biochemistry and his collaboration with fellow researchers underscore the importance of innovation in science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile